208
Views
1
CrossRef citations to date
0
Altmetric
Original Papers

Population dynamics of mesenchymal stromal cells during culture expansion

, , , , , & show all
Pages 401-411 | Received 24 Aug 2011, Accepted 08 Nov 2011, Published online: 13 Dec 2011

References

  • Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, . Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393–5.
  • Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7.
  • Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3:393–403.
  • Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, . Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974;2:83–92.
  • Dexheimer V, Mueller S, Braatz F, Richter W. Reduced reactivation from dormancy but maintained lineage choice of human mesenchymal stem cells with donor age. PLoS ONE. 2011;6:e22980.
  • Phinney DG. Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy. Cell Cycle. 2007;6:2884–9.
  • DiGirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol. 1999;107:275–81.
  • Ho AD, Wagner W, Franke W. Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy. 2008;10:320–30.
  • Wagner W, Ho AD. Mesenchymal stem cell preparations: comparing apples and oranges. Stem Cell Rev. 2007;3: 239–48.
  • Griesche N, Luttmann W, Luttmann A, Stammermann T, Geiger H, Baer PC. A simple modification of the separation method reduces heterogeneity of adipose-derived stem cells. Cells Tissues Organs. 2010;192:106–15.
  • Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA. 2001;98:7841–5.
  • Horn P, Bork S, Diehlmann A, Walenda T, Eckstein V, Ho AD, . Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis. Cytotherapy. 2008;10: 676–85.
  • Buhring HJ, Treml S, Cerabona F, de Zwart P, Kanz L, Sobiesiak M. Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Ann NY Acad Sci. 2009; 1176:124–34.
  • Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, de ZP, . Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica. 2009;94: 173–84.
  • Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci. 2000; 113:1161–6.
  • Delorme B, Ringe J, Pontikoglou C, Gaillard J, Langonne A, Sensebe L, . Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. Stem Cells. 2009;27:1142–51.
  • Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells. 2010;28:788–98.
  • Russell KC, Lacey MR, Gilliam JK, Tucker HA, Phinney DG, O'Connor KC. Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency. Biotechnol Bioeng. 2011;108:2716–26.
  • Wagner W. Senescence is heterogeneous in mesenchymal stromal cells: kaleidoscopes for cellular aging. Cell Cycle. 2010;9:2923–4.
  • Hayflick L, Moorhead P.S. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25:585–621.
  • Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol. 2000;28:707–15.
  • Noer A, Boquest AC, Collas P. Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence. BMC Cell Biol. 2007;8:18–22.
  • Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, . Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE. 2008;5:e2213.
  • Cholewa D, Stiehl T, Schellenberg A, Bokermann G, Joussen S, Koch C, . Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density. Cell Transplant. 2011;20:1409–22.
  • Horn P, Bokermann G, Cholewa D, Bork S, Walenda T, Koch C, . Comparison of individual platelet lysates for isolation of human mesenchymal stromal cells. Cytotherapy. 2010;12:888–98.
  • Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001;98:2615–25.
  • Staszewski R. Murphy's law of limiting dilution cloning. Stat Med 1990;9:457–61.
  • Underwood PA, Bean PA. Hazards of the limiting-dilution method of cloning hybridomas. J Immunol Methods. 1988;107:119–28.
  • Lietzke R, Unsicker K. A statistical approach to determine monoclonality after limiting cell plating of a hybridoma clone. J Immunol Methods. 1985;76:223–8.
  • Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, . Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.
  • Fraser JK, Wulur I, Alfonso Z, Zhu M, Wheeler ES. Differences in stem and progenitor cell yield in different subcutaneous adipose tissue depots. Cytotherapy. 2007;9:459–67.
  • Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, . Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol. 2005;33:1402–16.
  • Wagner W, Feldmann RE Jr, Seckinger A, Maurer MH, Wein F, Blake J, . The heterogeneity of human mesenchymal stem cell preparations. Evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol. 2006;34:536–48.
  • Wagner W, Roderburg C, Wein F, Diehlmann A, Frankhauser M, Schubert R, . Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells. 2007;10:2638–57.
  • Wagner W, Wein F, Roderburg C, Saffrich R, Faber A, Krause U, . Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell–cell interaction. Exp Hematol. 2007;35:314–25.
  • Schellenberg A, Lin Q, Schueler H, Koch C, Joussen S, Denecke B, . Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging (Albany NY). 2011;3:873–88.
  • Koch C, Suschek CV, Lin Q, Bork S, Goergens M, Joussen S, . Specific age-associated DNA methylation changes in human dermal fibroblasts. PLoS ONE. 2011;6:e16679.
  • Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, . Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211–28.
  • Noel D, Caton D, Roche S, Bony C, Lehmann S, Casteilla L, . Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res. 2008;314:1575–84.
  • Orriss IR, Utting JC, Brandao-Burch A, Colston K, Grubb BR, Burnstock G, . Extracellular nucleotides block bone mineralization in vitro: evidence for dual inhibitory mechanisms involving both P2Y2 receptors and pyrophosphate. Endocrinology. 2007;148:4208–16.
  • Fischer-Valuck BW, Barrilleaux BL, Phinney DG, Russell KC, Prockop DJ, O'Connor KC. Migratory response of mesenchymal stem cells to macrophage migration inhibitory factor and its antagonist as a function of colony-forming efficiency. Biotechnol Lett. 2010;32:19–27.
  • Sarugaser R, Hanoun L, Keating A, Stanford WL, Davies JE. Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS ONE. 2009; 4:e6498.
  • Peters R, Wolf MJ, van den Broek M, Nuvolone M, Dannenmann S, Stieger B, . Efficient generation of multipotent mesenchymal stem cells from umbilical cord blood in stroma-free liquid culture. PLoS ONE. 2010;5:e15689.
  • Wagner W, Bork S, Lepperdinger G, Joussen S, Ma N, Strunk D, . How to track cellular aging of mesenchymal stromal cells. Aging (Albany NY). 2010;2:224–30.
  • Smith JR, Braunschweiger KI. Growth of human embryonic fibroblasts at clonal density: concordance with results from mass cultures. J Cell Physiol. 1979;98:597–601.
  • Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, Leboff MS, . Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell. 2008;7:335–43.
  • Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 2006;7:14.
  • Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003;33:919–26.
  • Fehrer C, Lepperdinger G. Mesenchymal stem cell aging. Exp Gerontol. 2005;40:926–30.
  • Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells. 2004;22:675–82.
  • Lee S, Park JR, Seo MS, Roh KH, Park SB, Hwang JW, . Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells. Cell Prolif. 2009;42:711–20.
  • Fehrer C, Brunauer R, Laschober G, Unterluggauer H, Reitinger S, Kloss F, . Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell. 2007;6:745–57.
  • Holzwarth C, Vaegler M, Gieseke F, Pfister SM, Handgretinger R, Kerst G, . Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol. 2010;11:11.
  • Lindner U, Kramer J, Behrends J, Driller B, Wendler NO, Boehrnsen F, . Improved proliferation and differentiation capacity of human mesenchymal stromal cells cultured with basement-membrane extracellular matrix proteins. Cytotherapy. 2010;12:992–1005.
  • Bork S, Pfister S, Witt H, Horn P, Korn B, Ho AD, . DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell. 2010;9:54–63.
  • Wright WE, Shay JW. Historical claims and current interpretations of replicative aging. Nat Biotechnol. 2002;20:682–8.
  • Blackburn EH. Telomere states and cell fates. Nature. 2000;408:53–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.